FDA OKs Atlas Stent System, Wearables in Epilepsy Monitoring, and ASA Policy Statement on Stroke Care Systems
Neurology News Network for the week ending May 25, 2019.
PUBLISHED May 25, 2019
This week, Neurology News Network covered the FDA approval of Neuroform's Atlas Stent System for wide-neck intracranial aneurysms, the effectiveness of wearable epilepsy monitoring devices has been evaluated, and the new American Stroke Association's policy statement on updating stroke systems of care. (Transcript below).
Welcome to Neurology News Network. I’m Jenna Payesko.Let’s get into the news from this week.
The automated system detected epileptic seizures and psychogenic non‐epileptic seizures with a sensitivity of 72.7% and specificity of 100%. The positive and negative predictive values for PNES classification were 81.3% and 100%, respectively.
In light of recent advances in scientific knowledge and innovations in clinical care in stroke systems, the American Stroke Association published a policy statement to help guide policymakers and public healthcare agencies in updating stroke systems of care to reflect these advances, translating these developments into improvements in patient outcomes and facilitating optimal stroke care delivery.
The recommendations include early and primary prevention, acute stroke recognition and activation of emergency medical services, triage to appropriate facilities, the designation of treatment at stroke centers, secondary prevention at hospital discharge, and rehabilitation and recovery.
For more direct access to expert insight, head to neurologylive.com. This has been Neurology News Network. Thanks for watching.